DALAT, Vietnam, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, announced today that the Company has been meeting with high level Vietnamese government officials, regarding the establishment of advanced fiber production in Vietnam. Reports of these meetings have been receiving wide coverage in Vietnamese press and television.
An example of the Vietnamese coverage can be found at the following link:
"Vietnam is a nation with a wealth of infrastructure and experience in raw silk fiber production," said Company CEO and Founder, Kim K. Thompson. "We believe there is a natural fit between our desire to achieve large scale commercial production and Vietnam's desire to modernize its industry and increase productivity," continued Thompson.
"We are very excited about the possibility of working with Vietnam. Our discussions regarding commercial production have been very productive. We have been very well received and our hosts have been very gracious. I would like to thank the parties who have taken the time to help make this trip as fruitful as possible. I am very impressed with what I've seen in Vietnam, including their passion for sericulture," Thompson concluded.
The Company's CEO will continue a thorough evaluation and assessment process in Vietnam, before returning to the United States.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc